12:00 AM
Jan 02, 2012
 |  BC Week In Review  |  Company News  |  Deals

MorphoSys, Novozymes deal

MorphoSys granted enzyme supplier Novozymes non-exclusive rights to use MorphoSys' Slonomics technology to develop products for industrial biotechnology applications. Details...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >